Genpharmasec Ltd
NSE: BSE: 531592
₹1.16
(0%)
Thu, 28 May 2026, 06:09 pm
Market Cap642.31M
PE Ratio0
Dividend0
Process Industries
Chemicals: Specialty
24.5KGenpharmasec Analysis
dividend
- Unable to evaluate Generic Pharmasec's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Generic Pharmasec's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Generic Pharmasec is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Generic Pharmasec is profitable, therefore cash runway is not a concern.
- Generic Pharmasec is profitable, therefore cash runway is not a concern.
- Generic Pharmasec has no debt, it does not need to be covered by operating cash flow.
- Generic Pharmasec has no debt, it does not need to be covered by short term assets.
- Generic Pharmasec's cash and other short term assets cover its long term commitments.
- Generic Pharmasec currently has no debt however we can't compare to 5 years ago as we have no data for that period.
- Generic Pharmasec has no debt, therefore coverage of interest payments is not a concern.
- Generic Pharmasec has no debt.
- Low level of unsold assets.
management
- The average tenure for the Generic Pharmasec board of directors is less than 3 years, this suggests a new board.
misc
- Generic Pharmasec is not covered by any analysts.
- Generic Pharmasec has significant price volatility in the past 3 months.
past
- Generic Pharmasec's 1-year earnings growth exceeds its 5-year average (248.2% vs 59.6%)
- Generic Pharmasec has delivered over 20% year on year earnings growth in the past 5 years.
- Generic Pharmasec's earnings growth has exceeded the IN Trade Distributors industry average in the past year (248.2% vs 30.2%).
- Generic Pharmasec used its assets less efficiently than the IN Trade Distributors industry average last year based on Return on Assets.
- It is difficult to establish if Generic Pharmasec improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- Generic Pharmasec has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- 531592 outperformed the Trade Distributors industry which returned -5.6% over the past year.
- 531592 outperformed the Market in India which returned -14.5% over the past year.
- Generic Pharmasec is overvalued based on assets compared to the IN Trade Distributors industry average.
- Generic Pharmasec is overvalued based on earnings compared to the IN Trade Distributors industry average.
- Generic Pharmasec is overvalued based on earnings compared to the India market.
- BSE:531592 is down -21.7% underperforming the Trade Distributors industry which returned 6.8% over the past month.
- BSE:531592 is down -21.7% underperforming the market in India which returned 8% over the past month.